GENE ONLINE|News &
Opinion
Blog

COVID-19
Vaccine Inequity, How Pandemic Becomes Endemic
2022-05-03
Singapore’s RVAC Medicines Raises $140 Million for mRNA Ambitions
2022-04-28
Scientists Jointly Urge FDA to Evaluate T-Cell Response in Review of COVID-19 Vaccines
2022-04-27
Bio-Europe Spring: 2022 Europe Ophthalmic Medication Market Skyrockets
2022-04-20
Moderna Shares Promising Preliminary Bivalent COVID-19 Booster Results
2022-04-20
KKR-led Group Attempts $14.8 Billion Takeover of Australia’s Ramsay Health Care
2022-04-19
FDA Greenlights the First COVID-19 Breath Test
2022-04-15
Good or Bad: The 4th Dose of mRNA COVID Vaccine
2022-04-12
CUHK Researchers Discover Distinct Gut Microbial Signatures for Prediction, Diagnosis and Treatment of Long COVID
2022-04-11
Shionogi and Aichi Prefecture Extends Cooperation on Preventing Drug Abuse
2022-04-08
EUA of Monoclonal Antibodies Revoked: Are Oral COVID Drugs the Only Hope?
2022-04-06
How Do Tech Giants Like Google and Meta Improve Our Understanding of Public Health During Pandemic
2022-04-06
Kintor Pharma’s Proxalutamide Demonstrated Reduction in Hospitalization/Mortality for Patients with Mild to Moderate COVID-19 in Phase III MRCT Study
2022-04-05
UMP Healthcare Expands Free Telemedicine and Drug Delivery to COVID-19 Patients
2022-03-31
The Absence of Long COVID Treatment Plans Has Become a New Business Opportunity for Medium-sized Pharmas
2022-03-30
1 2 3 4 5 6 27
LATEST
Biotech in Beauty: Engineered Skin Bacteria Designed To Treat Acne
2024-05-10
Revolutionizing Treatment: ASGCT’s Clinical Trials Spotlight on Immunotherapy, Cancer Vaccines, and Auditory Diseases
2024-05-09
Advancing Health: ASGCT’s Clinical Trials Spotlight on Cell Therapy and Cell-Based Gene Therapy
2024-05-09
Infinitopes’ Article in Peer-Reviewed Journal Seeks to Unlock the Potential of Cancer Vaccines
2024-05-09
Profluent Achieves Human Genome Editing Milestone Using OpenCRISPR-1: The First AI-Generated, Open-Source Gene Editor
2024-05-08
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
EVENT
Scroll to Top